---
schema_version: "secwatch.filing_event.v1"
accession: "0000927066-21-000159"
form_type: "8-K"
ticker: "DVA"
cik: "0000927066"
company_name: "DAVITA INC."
filed_at: "2021-09-09T23:59:59+00:00"
generated_at: "2026-06-29T05:03:24.675752+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# DaVita expands board to nine, appoints Dr. Gregory J. Moore as director

## Summary
- Board size increased from 8 to 9 members effective September 9, 2021.
- Gregory J. Moore, M.D., Ph.D. appointed to fill new vacancy; also joins Nominating and Governance and Compliance and Quality Committees.
- Dr. Moore will receive standard non-employee director compensation and indemnification; no material transactions with the company.

## SEC filing metadata
- accession: 0000927066-21-000159
- form_type: 8-K
- ticker: DVA
- cik: 0000927066
- company_name: DAVITA INC.
- filed_at: 2021-09-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/927066/000092706621000159/0000927066-21-000159-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/927066/000092706621000159/dva-20210909.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000927066-21-000159
- JSON: https://secwatch.observer/filing/0000927066-21-000159.json
- Plain text: https://secwatch.observer/filing/0000927066-21-000159.txt

## Key facts
- Executive change
  Gregory J. Moore was appointed as Director at DAVITA INC..
  - Action: appointed
  - Role: Director
  source text: appointed Gregory J. Moore, M.D., Ph.D. as a member of the Board, to fill the newly created vacancy on the Board, in each case effective as of September 9, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/927066/000092706621000159/0000927066-21-000159-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.